Non categorizzato Novartis up 5% on upbeat guidance, earnings Aprile 23, 2024 0 commenti Novartis’ United States-listed stock soared by more than 5% on Tuesday’s premarket session after the company revealed its guidance for the full fiscal year 2024. The Swiss drugmaker’s sto… About the author:
Get involved!
Comments